IRIS Accounts Production v23.3.1.45 12499418 Board of Directors 1.4.22 31.3.23 31.3.23 false true false false true false Ordinary 1.00000 Ordinary A 1.00000 Ordinary B 1.00000 16421 16421 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh124994182022-03-31124994182023-03-31124994182022-04-012023-03-31124994182021-03-31124994182021-04-012022-03-31124994182022-03-3112499418ns10:Originalns15:EnglandWales2022-04-012023-03-3112499418ns14:PoundSterlingns10:Original2022-04-012023-03-3112499418ns10:Originalns10:Director12022-04-012023-03-3112499418ns10:Original2022-04-012023-03-3112499418ns10:Original2023-03-3112499418ns10:Originalns10:PrivateLimitedCompanyLtd2022-04-012023-03-3112499418ns10:Originalns10:SmallEntities2022-04-012023-03-3112499418ns10:Originalns10:AuditExempt-NoAccountantsReport2022-04-012023-03-3112499418ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-04-012023-03-3112499418ns10:SmallCompaniesRegimeForAccountsns10:Original2022-04-012023-03-3112499418ns10:Originalns10:FullAccounts2022-04-012023-03-3112499418ns10:Originalns10:OrdinaryShareClass12022-04-012023-03-3112499418ns10:Originalns10:OrdinaryShareClass22022-04-012023-03-3112499418ns10:OrdinaryShareClass3ns10:Original2022-04-012023-03-3112499418ns10:Original42ns10:Director22022-04-012023-03-3112499418ns10:Original42ns10:Director22023-03-3112499418ns10:Original2022-03-3112499418ns10:Originalns5:CurrentFinancialInstruments2023-03-3112499418ns10:Originalns5:CurrentFinancialInstruments2022-03-3112499418ns5:ShareCapitalns10:Original2023-03-3112499418ns5:ShareCapitalns10:Original2022-03-3112499418ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-03-3112499418ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-03-3112499418ns10:Originalns10:RegisteredOffice2022-04-012023-03-3112499418ns10:Originalns5:PlantMachinery2022-04-012023-03-3112499418ns10:Originalns5:FurnitureFittings2022-04-012023-03-3112499418ns10:Originalns5:ComputerEquipment2022-04-012023-03-3112499418ns10:Original2021-04-012022-03-3112499418ns10:Originalns5:PlantMachinery2022-03-3112499418ns10:Originalns5:FurnitureFittings2022-03-3112499418ns10:Originalns5:ComputerEquipment2022-03-3112499418ns10:Original2022-03-3112499418ns10:Originalns5:PlantMachinery2023-03-3112499418ns10:Originalns5:FurnitureFittings2023-03-3112499418ns10:Originalns5:ComputerEquipment2023-03-3112499418ns10:Originalns5:PlantMachinery2022-03-3112499418ns10:Originalns5:FurnitureFittings2022-03-3112499418ns10:Originalns5:ComputerEquipment2022-03-3112499418ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-3112499418ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-03-3112499418ns5:AcceleratedTaxDepreciationDeferredTaxns10:Original2023-03-3112499418ns5:AcceleratedTaxDepreciationDeferredTaxns10:Original2022-03-3112499418ns10:Originalns5:DeferredTaxation2022-03-3112499418ns10:Originalns5:DeferredTaxation2022-04-012023-03-3112499418ns10:Originalns5:DeferredTaxation2023-03-3112499418ns10:Originalns10:OrdinaryShareClass12023-03-3112499418ns10:Originalns10:OrdinaryShareClass22023-03-3112499418ns10:OrdinaryShareClass3ns10:Original2023-03-3112499418ns10:Originalns10:Director22022-04-012023-03-3112499418ns10:Original1ns10:Director12022-03-3112499418ns10:Original1ns10:Director12021-03-3112499418ns10:Original1ns10:Director12022-04-012023-03-3112499418ns10:Original1ns10:Director12021-04-012022-03-3112499418ns10:Original1ns10:Director12023-03-3112499418ns10:Original1ns10:Director12022-03-31
REGISTERED NUMBER: 12499418 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED

31 MARCH 2023

FOR

WILBURY MEDICAL LIMITED

WILBURY MEDICAL LIMITED (REGISTERED NUMBER: 12499418)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023










Page

Balance Sheet 1

Notes to the Financial Statements 3


WILBURY MEDICAL LIMITED (REGISTERED NUMBER: 12499418)

BALANCE SHEET
31 MARCH 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 5 1,647 1,445

CURRENT ASSETS
Debtors 6 19,566 4,941
Cash at bank 45,080 69,308
64,646 74,249
CREDITORS
Amounts falling due within one year 7 9,854 15,649
NET CURRENT ASSETS 54,792 58,600
TOTAL ASSETS LESS CURRENT
LIABILITIES

56,439

60,045

PROVISIONS FOR LIABILITIES 8 313 275
NET ASSETS 56,126 59,770

CAPITAL AND RESERVES
Called up share capital 9 100 100
Retained earnings 56,026 59,670
SHAREHOLDERS' FUNDS 56,126 59,770

WILBURY MEDICAL LIMITED (REGISTERED NUMBER: 12499418)

BALANCE SHEET - continued
31 MARCH 2023


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 30 November 2023 and were signed on its behalf by:





Dr T M Whitfield - Director


WILBURY MEDICAL LIMITED (REGISTERED NUMBER: 12499418)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023


1. STATUTORY INFORMATION

Wilbury Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 12499418

Registered office: 48 St Leonards Road
Bexhill on Sea
East Sussex
TN40 1JB

The presentation currency of the financial statements is the Pound Sterling (£).


2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents the invoiced value of services supplied by the company during the year, after adjusting for accrued income at the year end.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Equipment - 20% on reducing balance
Fixtures and fittings - 33% on cost
Computer Equipment - 33% on cost

All fixed assets are initially recorded at cost.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


WILBURY MEDICAL LIMITED (REGISTERED NUMBER: 12499418)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2023


3. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Financial instruments
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities.

Where the contractual obligations of financial instruments (including share capital) are equivalent to a similar debt instrument, those financial instruments are classed as financial liabilities. Financial liabilities are presented as such in the balance sheet. Finance costs and gains or losses relating to financial liabilities are included in the profit and loss account. Finance costs are calculated so as to produce a constant rate of return on the outstanding liability.

Where the contractual terms of share capital do not have any terms meeting the definition of a financial liability then this is classed as an equity instrument. Dividends and distributions relating to equity instruments are debited direct to equity.

4. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2022 - 2 ) .

WILBURY MEDICAL LIMITED (REGISTERED NUMBER: 12499418)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2023


5. TANGIBLE FIXED ASSETS
Fixtures
and Computer
Equipment fittings Equipment Totals
£    £    £    £   
COST
At 1 April 2022 1,104 300 830 2,234
Additions - - 1,076 1,076
At 31 March 2023 1,104 300 1,906 3,310
DEPRECIATION
At 1 April 2022 412 100 277 789
Charge for year 139 100 635 874
At 31 March 2023 551 200 912 1,663
NET BOOK VALUE
At 31 March 2023 553 100 994 1,647
At 31 March 2022 692 200 553 1,445

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Directors' current account 16,421 -
Prepayments and accrued income 3,145 4,941
19,566 4,941

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade creditors 1,632 -
Corporation tax 6,522 13,502
Directors' current account - 588
Accruals and deferred income 1,700 1,559
9,854 15,649

8. PROVISIONS FOR LIABILITIES
2023 2022
£    £   
Deferred tax
Accelerated capital allowances 313 275

WILBURY MEDICAL LIMITED (REGISTERED NUMBER: 12499418)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2023


8. PROVISIONS FOR LIABILITIES - continued

Deferred
tax
£   
Balance at 1 April 2022 275
Provided during year 38
Balance at 31 March 2023 313

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
80 Ordinary £1 80 80
10 Ordinary A £1 10 10
10 Ordinary B £1 10 10
100 100

10. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 March 2023 and 31 March 2022:

2023 2022
£    £   
Dr T M Whitfield and Mrs A Whitfield
Balance outstanding at start of year - -
Amounts advanced 16,421 -
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 16,421 -

Loans to the directors of under £10,000 per director, are interest free and repayable on demand.